IL17A and neoplasm: Recently it has been shown that OSCC-derived EVs induce overactivation of the IL-17A-signaling pathway in tumor tissue, causing an inflammatory cytokine imbalance in the tumor microenvironment, and thus promote OSCC xenograft tumor growth [127].